Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-03-27
1999-11-02
Stanton, Brian R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 44, 424 9463, 424350, 424337, 424520, 530355, 530855, A01N 3718, A61K 3800, A61K 3848, C07K 100
Patent
active
059770562
ABSTRACT:
A method for preventing the formation of platelet-rich clots or thrombus, and for deaggregating platelet-rich clots or thrombus, using hementin, a polypeptide derived from leech salivary glands. Hementin may be administered for this purpose in a pharmaceutically acceptable carrier or excipient, with or without additional anticoagulants such as hirudin, hirudin analogues, or an inhibitor of factor Xa.
REFERENCES:
patent: 4390630 (1983-06-01), Sawyer et al.
patent: 4832849 (1989-05-01), Cardin
Malinconico et al., "Fabrinogen degradation by hementin, a fibrinogenolytic anticoagulant from the salivary glands of the leech Haementeria ghilanii," J. Lab. Clin. Med., vol. 104, No. 5, (Nov. 1984).
Munro et al., "Effects of Hementin on Fibrinogen Mediated Platelet Aggregation/Deaggregation In Vitro," Platelets, 2:167-168 (1991).
Yasuda et al., "Lysis of Plasminogen Activator-Resistant Platelet-Rich Coronary Artery Thrombus With Combined Bolus Injection of Recombinant Tissue-Type Plasminogen Activator and Antiplatelet GPIIb/IIIa Antibody," JACC, vol. 16, No. 7, 1728-35, (Dec. 1990).
Forth et al., "Pharmakotherapie von Storungen der Blutgerinnung," Antikoagulantien, Aggregationshemmer, Fibrinolytika Und Hemmstoffe Der Fibrinolyse, 437-456.
Edwin L. Madison et al. (1989) Nature, vol. 339, pp. 721-724.
Scott M. Malinconico et al. (1984) J. Lab. Clin. Med., vol. 104(5), pp. 842-854.
Nancy E. Kirschbaum et al. (1990) J. Biol. Chem., vol. 265(23), pp. 13669-13676.
R.T. Sawyer et al. (1991) Blood Coagulation and Fibrinolysis, vol. 2, pp. 153-159.
J.K. Swadesh et al. (1990) J. Chromatography, vol. 502, pp. 359-369.
Blankenship et al. (1990) Biochem. Biophys. Res. Comm., vol. 166, pp. 1384-1389.
Muller et al. (Eds) 1981. in "Neurobiology of the Leech", Cold Spring Harbor Laboratory, N.Y. pp. 7-26.
Kramer et al. 1981. J Comp Physiol A Sensneural Behav Physiol. 144(4):435-448--(Biosis Abstract only-AN 73068936).
Malinconico et al. 1984. J. Lab. Clin. Med. 103(1):44-58.
Mao et al. 1988. Biochemistry 27:8170-8173.
Atkinson Anthony
Electricwala Asgar
Powell-Jones Christopher
Sawyer Roy T.
Biopharm (UK) Limited
Martin Jill D.
Stanton Brian R.
LandOfFree
Treatment of thrombotic events does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of thrombotic events, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of thrombotic events will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2135475